San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Arena Weighs Advantages, Decides to Deal Belviq to Eisai

San Diego drugmaker Arena Pharmaceuticals Inc. is unloading its only FDA-approved drug, the anti-obesity pill Belviq, to its longtime Japanese partner, Eisai Co. Ltd.

Tease photo

C-Suite Shuffle at Amplyx Pharmaceuticals

Mike Grey, a veteran of the biotech industry, is stepping aside from his role at Amplyx Pharmaceuticals Inc. and handing the reins to Ciara Kennedy, the company’s chief operating officer.

Tease photo

Mary Naggs Joins Executive Team at Apricus Biosciences

Local drugmaker Apricus Biosciences Inc. has promoted its internal associate general counsel, Mary Naggs, to the company’s executive team.

Tease photo

Dr. Michael Sise Named Chief of Staff at Scripps

Vascular surgeon Dr. Michael Sise has been elected chief of staff by doctors at Scripps Mercy Hospital’s Hillcrest and Chula Vista campuses.

Tease photo

Arena Pharmaceuticals Bails on Its Weight-Loss Drug

San Diego drugmaker Arena Pharmaceuticals Inc. is unloading its only FDA-approved drug, the anti-obesity pill Belviq, to its longtime Japanese partner, Eisai Co. Ltd.

Tease photo

Genomics Pioneer Craig Venter Relinquishing CEO Role at HLI

Local genomics legend J. Craig Venter is stepping aside from his post as chief executive officer of Human Longevity Inc., turning over the helm to former GE Healthcare executive Cynthia Collins.

Poseida Therapeutics Hires Regulatory Affairs Expert

Poseida Therapeutics Inc., a local firm using gene editing to develop medicines, announced that Debra Gessner, an expert in regulatory affairs, will join the company’s executive team.

Tease photo

Life Sciences Aim to Shake Off the Ailments of a Tough 2016

Economic Trends: Life Sciences

It’s been a rather down year for San Diego’s life science industry, no matter what the industry groups say.

Tease photo

Ability to Adapt Keeps Health Care Industry Responsive, Ready

Economic Trends: Health Care

The year ahead threatens severe disruption to a local health care industry still trying to deliver on its key values — quality and affordability — in the face of major technological changes to virtually every aspect of its operations. So, what else is new?

VC Group Based in Italy Invests $4 Million in AnaBios Corp.

An Italy-based venture capital group has invested more than $4 million in San Diego biotechnology company AnaBios Corp., which aims to raise a total of $10 million in a Series B financing round.

Sharp Grossmont Hospital Takes Big Step in Energy Independence

Sharp Grossmont Hospital is operating independently of the state power grid following completion of a taxpayer-funded energy plant.

Timothy Coughlin Leaving CFO Post at Neurocrine Biosciences

Local drugmaker Neurocrine Biosciences Inc. said its chief financial officer, Timothy Coughlin, is stepping down.

A Shaky Q4 Leaves Few Winners in Rattled Biotech Stocks

INVESTMENT: Ionis Pharmaceuticals Manages To Extend Its Successes

The fourth quarter of 2016 has been a roller coaster for the life science industry, with investors celebrating the presidential election results a tad preemptively. As a result, stock prices have soared and then nearly immediately tanked.

Tease photo

HMO Competition Changes Care in Baja

MEDICINE: New Hospital Will Expand Offerings

Local employers looking to offer health benefits to workers living south of the U.S.-Mexico border are finding a new level of sophistication, as demand for low-cost, quality medicine has spawned new competition and distinct approaches to HMO care in Baja California.

California Cancer Associates Leases Space in San Marcos

San Diego-based oncology and hematology practice California Cancer Associates for Research and Excellence, or cCARE, has signed a lease for 20,230 square feet at the Nordahl Medical Centre in San Marcos.